Sorrento Therapeutics Inc (SRNE): Sorrento has a broad portfolio because o...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Wednesday, 02/23/2022 12:42:55 PM

Wednesday, February 23, 2022 12:42:55 PM

Sorrento has a broad portfolio because of many very good investments, partnerships and acquisitions. A good example is SP-104, a drug to treat fibromyalgia, which they acquired from Aardvark Therapeutics. It has completed phase 1 late in 2021.
Sorrento has also been a lead investor in private Aardvark. And this month Aardvark initiated 3 phase 2 trials targeting the very large anti-obesity market. Furthermore Aardvark intends to engage in an IPO very soon. Another very attractive Sorrento investment! For an overview of Aardvark you can watch this...
https://journey.ct.events/view/0898f4ce-f101-4428-b057-a98405ee5ebc

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM